EridanusPills logotype

Cart: Your cart is empty

    Payment Methods:
  • Visa payment logo
  • Mastercard payment logo

Hours of Operation 24/7

Buy Dolo-Puren

600 mg, 400 mg

Dolo-Puren tablets 600 mg, 400 mg image

Active ingredient: ibuprofen

Buy Now
Categories of Dolo-PurenArthritis
Average price (USD)$0.87
Manufacturer country (Worldwide Sale)
Medication ClassNonsteroidal anti-inflammatory agents

Dolo-Puren pills OTC

Do not give nonprescription ibuprofen to a child who has a mixture throat that is high doses or open link not using away, Dolo-Puren that comes along with fever, headache, nausea, or vomiting. Ibuprofen works by blocking the production of prostaglandins, substances that the body releases in response to illness and injury. In cats, there has never been success with the use of ibuprofen, and with dogs, they have a very narrow therapeutic range. Ibuprofen dose for a child 36 to 47 pounds.

Side Effects

Possible side effects of Dolo-Puren include:

  • unusual bleeding or bruising
  • drowsiness to profound coma
  • coma
  • difficulty having a bowel movement (stool)
  • blistering, peeling, loosening of skin

Used for

Dolo-Puren is used to treat diseases such as: Aseptic Necrosis, Back Pain, Chronic Myofascial Pain, Costochondritis, Diffuse Idiopathic Skeletal Hyperostosis, Dysautonomia, Fever, Frozen Shoulder, Gout, Acute, Headache, Juvenile Rheumatoid Arthritis, Muscle Pain, Neck Pain, Osteoarthritis, Pain, Patent Ductus Arteriosus, Period Pain, Plantar Fasciitis, Radiculopathy, Rheumatoid Arthritis, Sciatica, Spondylolisthesis, Temporomandibular Joint Disorder, Toothache, Transverse Myelitis.

How to Use

  • Use 1 or 2 sprays in both nostrils, usually once or twice a day as directed by your doctor.
  • Read all of this leaflet carefully before you start taking this.

Dosage & Overdose

It is important to use this medication exactly as prescribed by your doctor. Excessive doses of the drug induce hypercalcemia and hypercalciuria.


  • Our study showed no association between prolonged rupture of membranes and increased risk of HIV transmission.
  • Prolonged systemic use of calcineurin inhibitors for sustained immunosuppression in animal studies and transplant patients following systemic administration has been associated with an increased risk of infections, lymphomas, and skin malignancies.